Nelson Dusetti and Nicolas Frauhoffer
Oct 27, 2024, 09:26
Nelson Dusetti: Modeling the Intratumoral Dynamics of Pancreatic Cancer to Target Resistant Phenotypes
Nelson Dusetti shared a post on X:
”Modeling the Intratumoral Dynamics of Pancreatic Cancer to Target Resistant Phenotypes.
We are grateful to Fondation ARC for funding this project. This support is vital for our team and will be a key pillar in the years to come. Nicolas Frauhoffer, will lead this initiative.”
Nelson Dusetti is Scientific Director of the company Predicting Med (CSO) and Chair of TRANSLATE-IT CRCM. He is also research director at INSERM. He is the Head of the Department of Translational Research and Innovative Therapies at CRCM.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 30, 2024, 13:52
Dec 30, 2024, 13:42
Dec 30, 2024, 13:23